Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine

By Papadopoulos I.   Rudolph P.   Weichert-Jacobsen K.   Thiemann O.   Papadopoulou D.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 373-378

Elsevier

Access to resources Recommend Favorite

Lymphocyte subpopulations: prognostic value of patients with renal cell carcinoma under therapy with IL-2 and IFN-alpha

By Hillig F.   Schneider T.   Zacharias M.   Langner J.   Fornara P.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 141-141

Elsevier

Access to resources Recommend Favorite

Predicting survival of patients with metastatic renal cell carcinoma

By Motzer R.   Mazumdar M.  

Der Urologe A, Vol. 43, Iss. 3, 2004-09 ,pp. : 135-136

Springer Publishing Company

Access to resources Recommend Favorite

Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis - the prognostic significance of the level of vena caval involvement

By Polascik T.J.   Partin A.W.   Pound C.R.   Marshall F.F.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 995-999

Elsevier

Access to resources Recommend Favorite

High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experience

By Shulman K.L.   Stadler W.M.   Vogelzang N.J.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 194-197

Elsevier

Access to resources Recommend Favorite